Connect Biopharma Holdings Limited (CNTB)Healthcare | Biotechnology | San Diego, United States | NasdaqGM
2.68 USD
-0.13
(-4.626%) ⇩
(April 20, 2026, 4 p.m.
EDT)
Short-term: ★★★★☆ | Long-term: ★★★★☆ | Dividends: ★★★★★ |
Hot Take | April 18, 2026, 10:24 p.m. EDT
Despite the massive cash raise and insider accumulation, the lack of dividend growth and negative EA/Share growth masks a significant value pivot here; CNTB is effectively being bought purely on clinical catalysts and the de-risking of its cash balance sheet, making it a solid 'Hamster Wheel' high-beta hold (4 stars) rather than a deep value play (0 on fundamental growth due to negative figures), though the yield is technically infinite due to the lack of payouts to deleverage the balance sheet. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.063643 |
| MSTL | 0.071173 |
| AutoETS | 0.073458 |
| AutoARIMA | 0.132611 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 57% |
| H-stat | 1.36 |
| Ljung-Box p | 0.030 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 2.15 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.644 |
| Revenue per Share | 0.001 |
| Market Cap | 151,477,040 |
| Forward P/E | -3.59 |
| Website | https://www.connectbiopharm.com |
As of April 18, 2026, 10:24 p.m. EDT: The options market shows a distinct bullish bias in speculative positioning. For the near-term expiration (04-17), despite the low implied volatility environment (ATM IV ~5%), there is a massive volume of calls traded at the current price (ATM) compared to puts, suggesting immediate bets on upside momentum. Conversely, put volume is almost entirely confined to OTM strikes lower than current price, acting as a hedge for downside rather than an expression of imminent crash expectations. The IV crush suggests the market expects a static price, but the flow imbalance favors upside.
| Attribute | Value |
|---|---|
| 52 Week Change | 2.8285713 |
| Address1 | 3,580 CARMEL MOUNTAIN ROAD |
| Address2 | SUITE 200 |
| All Time High | 29.274 |
| All Time Low | 0.51 |
| Ask | 2.7 |
| Ask Size | 2 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 379,530 |
| Average Daily Volume3 Month | 236,747 |
| Average Volume | 236,747 |
| Average Volume10Days | 379,530 |
| Bid | 2.62 |
| Bid Size | 1 |
| Book Value | 0.744 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.68 |
| Current Ratio | 3.741 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 3.0299 |
| Day Low | 2.61 |
| Debt To Equity | 1.644 |
| Display Name | Connect Biopharma |
| Earnings Timestamp End | 1,758,283,200 |
| Earnings Timestamp Start | 1,757,069,940 |
| Ebitda | -57,370,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.879 |
| Enterprise To Revenue | 1,684.766 |
| Enterprise Value | 107,825,032 |
| Eps Current Year | -0.8675 |
| Eps Forward | -0.7475 |
| Eps Trailing Twelve Months | -1.0 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.7746 |
| Fifty Day Average Change | -0.09459996 |
| Fifty Day Average Change Percent | -0.03409499 |
| Fifty Two Week Change Percent | 282.85712 |
| Fifty Two Week High | 3.82 |
| Fifty Two Week High Change | -1.1399999 |
| Fifty Two Week High Change Percent | -0.29842928 |
| Fifty Two Week Low | 0.65 |
| Fifty Two Week Low Change | 2.0300002 |
| Fifty Two Week Low Change Percent | 3.1230774 |
| Fifty Two Week Range | 0.65 - 3.82 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,616,160,600,000 |
| Float Shares | 12,027,729 |
| Forward Eps | -0.7475 |
| Forward P E | -3.5852845 |
| Free Cashflow | -30,651,250 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 64 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 64,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.3806 |
| Held Percent Institutions | 0.52975 |
| Implied Shares Outstanding | 56,521,282 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-03-19 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California. |
| Long Name | Connect Biopharma Holdings Limited |
| Market | us_market |
| Market Cap | 151,477,040 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_706016439 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -55,480,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 151,477,035 |
| Number Of Analyst Opinions | 5 |
| Open | 2.8 |
| Operating Cashflow | -51,206,000 |
| Operating Margins | -907.40625 |
| Payout Ratio | 0.0 |
| Phone | 858 727 1040 |
| Pre Market Change | 0.14999986 |
| Pre Market Change Percent | 5.5970097 |
| Pre Market Price | 2.83 |
| Pre Market Time | 1,776,770,909 |
| Previous Close | 2.81 |
| Price Eps Current Year | -3.089337 |
| Price Hint | 4 |
| Price To Book | 3.6021504 |
| Price To Sales Trailing12 Months | 2,366.8289 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.269 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.13 |
| Regular Market Change Percent | -4.62633 |
| Regular Market Day High | 3.0299 |
| Regular Market Day Low | 2.61 |
| Regular Market Day Range | 2.61 - 3.0299 |
| Regular Market Open | 2.8 |
| Regular Market Previous Close | 2.81 |
| Regular Market Price | 2.68 |
| Regular Market Time | 1,776,715,201 |
| Regular Market Volume | 416,150 |
| Return On Assets | -0.46132 |
| Return On Equity | -0.82716006 |
| Revenue Growth | -1.0 |
| Revenue Per Share | 0.001 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 56,521,282 |
| Shares Percent Shares Out | 0.0106 |
| Shares Short | 601,458 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 304,407 |
| Short Name | Connect Biopharma Holdings Limi |
| Short Percent Of Float | 0.015800001 |
| Short Ratio | 2.19 |
| Source Interval | 15 |
| State | CA |
| Symbol | CNTB |
| Target High Price | 10.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 7.9 |
| Target Median Price | 7.5 |
| Total Cash | 44,342,000 |
| Total Cash Per Share | 0.785 |
| Total Debt | 690,000 |
| Total Revenue | 64,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.21802 |
| Two Hundred Day Average Change | 0.4619801 |
| Two Hundred Day Average Change Percent | 0.20828491 |
| Type Disp | Equity |
| Volume | 416,150 |
| Website | https://www.connectbiopharm.com |
| Zip | 92,130 |